- Home
- GMED vs ELAN Comparison
GMED vs ELAN Comparison
Compare GMED & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GMED | ELAN |
|---|---|---|
| Founded | 2003 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.7B |
| IPO Year | 2012 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GMED | ELAN |
|---|---|---|
| Price | $93.88 | $22.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 10 |
| Target Price | ★ $100.42 | $27.89 |
| AVG Volume (30 Days) | 974.8K | ★ 4.1M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 422.67 | N/A |
| EPS | ★ 3.92 | N/A |
| Revenue | $2,938,931,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $11.13 | $8.21 |
| Revenue Next Year | $6.28 | $5.31 |
| P/E Ratio | $24.67 | ★ N/A |
| Revenue Growth | ★ 16.65 | 6.22 |
| 52 Week Low | $51.79 | $9.14 |
| 52 Week High | $101.40 | $27.72 |
Technical Indicators
Market Signals| Indicator | GMED | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 57.61 | 42.87 |
| Support Level | $85.01 | $22.17 |
| Resistance Level | $97.87 | $25.65 |
| Average True Range (ATR) | 3.04 | 0.92 |
| MACD | 0.66 | 0.00 |
| Stochastic Oscillator | 71.73 | 28.15 |
Price Performance
Historical ComparisonAbout GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.